Valuation : Integra LifeSciences Holdings Corporation

Market Cap 131.05Cr 112.92Cr 105.88Cr 97Cr 182.07Cr 13TCr 182.65Cr 1.26TCr 490.1Cr 6.32TCr 492.01Cr 481.31Cr 21TCr P/E 2026 *
26.3x
P/E 2027 * 13.5x
Enterprise Value 279.98Cr 241.26Cr 226.2Cr 206.49Cr 389Cr 27TCr 390.24Cr 2.68TCr 1.05TCr 14TCr 1.05TCr 1.03TCr 45TCr EV / Sales 2026 *
1.67x
EV / Sales 2027 * 1.5x
Free-Float
72.35%
Yield 2026 *
-
Yield 2027 * -
1 day+0.24%
1 week+0.90%
Current month+1.44%
1 month-14.52%
3 months+2.61%
6 months+61.94%
Current year+35.99%
1 week 16.39
Extreme 16.39
17.33
1 month 16.04
Extreme 16.04
19
Current year 8.7
Extreme 8.7
20.49
1 year 8.7
Extreme 8.7
20.49
3 years 8.7
Extreme 8.7
45.42
5 years 8.7
Extreme 8.7
76.7
10 years 8.7
Extreme 8.7
77.4
Manager TitleAgeSince
Chief Executive Officer 64 01/05/2026
Director of Finance/CFO 54 28/06/2023
Chief Tech/Sci/R&D Officer - 17/02/2026
Director TitleAgeSince
Chairman 64 03/01/2012
Director/Board Member 81 01/01/1992
Director/Board Member 65 01/01/2006
Date Insider Type Main position Quantity % Market Cap.
03/07/26 Tax

Chief Financial Officer

-5,226 0.0067%
01/07/26 Free

Executive/Senior Manager

5,590 0.0072%
01/07/26 Free

Executive/Senior Manager

11,180 0.0144%
Change 5-day change 1-year change 3-year change Capi.($)
+0.24%+0.90%+13.81%-60.07% 131.05Cr
+0.79%-3.58%-14.39%+9.42% 19TCr
+1.40%-2.27%-0.79%+12.09% 12TCr
+0.25%+1.25%+11.09%+78.52% 6.13TCr
-0.25%-3.31%+27.04%+55.45% 5.14TCr
+0.74%-1.29%-0.90%-32.69% 5.12TCr
+1.71%-1.65%+20.96%-8.53% 3.37TCr
+1.82%+2.98% - - 3.04TCr
-2.49%-4.42%+37.49%-16.34% 2.44TCr
-0.82%-1.46%-5.14%+22.13% 2.37TCr
Average +0.40%-0.00%+9.91%+6.66% 5.86TCr
Weighted average by Cap. +0.85%-1.04%+1.20%+16.13%

Financials

2026 *2027 *
Net sales 167.44Cr 144.28Cr 135.28Cr 123.49Cr 232.64Cr 16TCr 233.38Cr 1.6TCr 626.21Cr 8.08TCr 628.65Cr 614.97Cr 27TCr 172.8Cr 148.9Cr 139.61Cr 127.44Cr 240.09Cr 17TCr 240.85Cr 1.66TCr 646.26Cr 8.34TCr 648.78Cr 634.66Cr 28TCr
Net income 4.2Cr 3.62Cr 3.4Cr 3.1Cr 5.84Cr 401.72Cr 5.86Cr 40Cr 16Cr 202.79Cr 16Cr 15Cr 672.41Cr 7.87Cr 6.78Cr 6.36Cr 5.8Cr 11Cr 752.1Cr 11Cr 75Cr 29Cr 379.66Cr 30Cr 29Cr 1.26TCr
Net Debt 148.93Cr 128.34Cr 120.33Cr 109.84Cr 206.92Cr 14TCr 207.58Cr 1.43TCr 556.99Cr 7.19TCr 559.17Cr 547Cr 24TCr 128.49Cr 110.72Cr 103.81Cr 95Cr 178.52Cr 12TCr 179.09Cr 1.23TCr 480.55Cr 6.2TCr 482.42Cr 471.93Cr 21TCr
Logo Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is a global medical technology company. It manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.
Employees
4,427
Date Price Change Volume
29/26/29 $16.89 +0.24% 7,76,237
27/26/27 $16.85 -0.18% 4,49,758
26/26/26 $16.88 +0.54% 4,89,357
25/26/25 $16.79 +0.60% 3,69,535
24/26/24 $16.69 -0.30% 6,54,658
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
16.85USD
Average target price
19.56USD
Spread / Average Target
+16.06%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IART Stock